癌症治療市場：依治療類型、癌症類型和地區分類

2025 年全球癌症治療市場規模估計為 2,309.6 億美元，預計到 2032 年將達到 5,303.7 億美元，2025 年至 2032 年的複合年成長率為 12.6%。

數字。 2025 年各地區癌症治療市場佔有率（%）

癌症繼續對世界範圍的醫學造成重大挑戰。許多國家人口快速老化導致癌症發生率上升。此外，環境污染加劇和生活方式的改變，如不健康的飲食、缺乏運動、吸煙和飲酒，也會增加人們罹患癌症的風險。儘管治療性介入取得了進展，但癌症死亡率仍然很高。因此，最近的腫瘤學藥物開發活動集中在改善患者的治療效果和生活品質。

市場動態

癌症治療市場受到多種因素的推動，例如由於生活方式的改變導致全球癌症發病率增加、人口老齡化加劇、標靶治療和個性化醫療的採用日益增多、新興國家醫療基礎設施的擴大以及製藥公司對腫瘤學研發的投資增加。然而，癌症治療的高昂費用阻礙了其廣泛應用。此外，核准核准週期較長也在一定程度上對市場成長帶來挑戰。另一方面，強大的癌症臨床測試管道和生物相似藥的進入為預測期內的市場擴張提供了巨大的機會。

研究的主要特點

• 本報告對全球癌症治療市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
• 它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 全球癌症治療市場的主要企業已根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行了分析。
• 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 全球癌症治療市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員將透過全球癌症治療市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 收購和合作場景
• 贖回情況
• 流行病學
• 治療流程（病人歷程）
• 癌症診斷和治療方案
• 管道分析
• 患者權益倡導與賦權
• 監管情景
• 定價分析
• PEST分析
• 波特分析

第4章 全球癌症治療市場-冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 2020 年至 2032 年全球癌症治療市場（按治療類型分類）（十億美元）

• 介紹
• 化療
• 烷化劑
• 抗代謝物
• 抗腫瘤抗生素
• 其他
• 標靶治療
• 單株抗體
• 小分子抑制劑
• 其他
• 免疫療法
• 免疫查核點抑制劑
• 溶瘤病毒治療
• T細胞治療
• 放射治療
• 其他

6. 2020 年至 2032 年全球癌症治療市場（按癌症類型分類）（十億美元）

• 介紹
• 乳癌
• 肺癌
• 大腸直腸癌
• 攝護腺癌
• 血癌
• 肝癌
• 甲狀腺癌
• 頭頸癌
• 皮膚癌
• 其他

7. 2020 年至 2032 年全球癌症治療市場（按地區分類）（十億美元）

• 介紹
• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章 競爭格局

• 公司簡介
  • Bristol-Myers Squibb Company
  • AstraZeneca
  • Pfizer Inc.
  • Novartis AG
  • GSK plc.
  • Sanofi
  • Bayer AG
  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Boehringer Ingelheim International GmbH
  • ADC Therapeutics SA
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Eureka Therapeutics, Inc.
  • AbbVie Inc.
  • Fate Therapeutics
  • Sorrento Therapeutics, Inc.
  • Carrick Therapeutics Limited
  • Atara BIoTherapeutics, Inc.
  • Celluris
  • NeoTX
  • Kazia Therapeutics Limited

第 9 章 分析師觀點

• 興衰
• 一致的機會地圖

第10章參考文獻與調查方法

• 參考
• 調查方法

Global Cancer Therapy Market is estimated to be valued at USD 230.96 Bn in 2025 and is expected to reach USD 530.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2032.

Figure. Cancer Therapy Market Share (%), By Region 2025

Cancer continues to pose significant healthcare challenges worldwide. Rapidly aging population profiles in numerous countries have contributed to the rising cancer prevalence. Furthermore, increasing environmental pollution levels and lifestyle changes such as unhealthy diets, lack of physical activity, tobacco use, and alcohol consumption have elevated the cancer risk in populations. Despite advancements in therapeutic interventions, cancer mortality remains substantial. As a result, drug development activity in the oncology sector has intensified in recent times focused on improving patient outcomes and quality of life.

Market Dynamics:

The cancer therapy market is driven by various factors such as the increasing prevalence of cancer worldwide owing to changing lifestyle patterns, growing geriatric population, increasing adoption of targeted therapies and personalized medicine, expansion of healthcare infrastructure across emerging nations, and rising investment in cancer R&D by pharmaceutical companies. However, high treatment costs associated with cancer care pose limitations to widespread adoption. Moreover, long regulatory approval timelines for new drug approvals also challenge market growth to some extent. Meanwhile, robust cancer clinical trial pipelines and the entry of biosimilars provide significant opportunities for market expansion over the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global cancer therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global cancer therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Novartis AG, GSK plc., Sanofi, Bayer AG, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., ADC Therapeutics SA, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Eureka Therapeutics, Inc., AbbVie Inc., Fate Therapeutics, Sorrento Therapeutics, Inc., Carrick Therapeutics Limited, Atara Biotherapeutics, Inc., Celluris, NeoTX, and Kazia Therapeutics Limited.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global cancer therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapy market.

Detailed Segmentation-

• Therapy Type:
  • Chemotherapy
  • Alkylating agents
  • Antimetabolites
  • Anti-tumor antibiotics
  • Others
  • Target Therapy
  • Monoclonal antibodies
  • Small molecule inhibitors
  • Others
  • Immunotherapy
  • Immune Checkpoint Inhibitors
  • Oncolytic virus therapy
  • T-cell therapy
  • Radiotherapy
  • Others
• Cancer Type:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Blood Cancer
  • Liver Cancer
  • Thyroid Cancer
  • Head and Neck Cancer
  • Skin Cancer
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AstraZeneca
  • Pfizer Inc.
  • Novartis AG
  • GSK plc.
  • Sanofi
  • Bayer AG
  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Boehringer Ingelheim International GmbH.
  • ADC Therapeutics SA
  • Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Eureka Therapeutics, Inc.
  • AbbVie Inc.
  • Fate Therapeutics
  • Sorrento Therapeutics, Inc.
  • Carrick Therapeutics Limited
  • Atara Biotherapeutics, Inc.
  • Celluris
  • NeoTX
  • Kazia Therapeutics Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Therapy Type
  • Market Snapshot, By Cancer Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Acquisitions and Partnerships Scenario
• Reimbursement Scenario
• Epidemiology
• Treatment Algorithm (Patient Journey)
• Cancer Diagnosis and Treatment Options
• Pipeline Analysis
• Patient Advocacy and Empowerment
• Regulatory Scenario
• Pricing Analysis
• PEST Analysis
• PORTER's Analysis

4. Global Cancer Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 impact on the market

5. Global Cancer Therapy Market, By Therapy Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Chemotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Alkylating agents
• Antimetabolites
• Anti-tumor antibiotics
• Others
• Target Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Monoclonal antibodies
• Small molecule inhibitors
• Others
• Immunotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immune Checkpoint Inhibitors
• Oncolytic virus therapy
• T-cell therapy
• Radiotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cancer Therapy Market, By Cancer Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Breast Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Lung Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Colorectal Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prostate Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Blood Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Liver Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Thyroid Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Head and Neck Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Skin Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cancer Therapy Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Bristol-Myers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GSK plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
  • Bayer AG
  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Boehringer Ingelheim International GmbH.
  • ADC Therapeutics SA
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Eureka Therapeutics, Inc.
  • AbbVie Inc.
  • Fate Therapeutics
  • Sorrento Therapeutics, Inc.
  • Carrick Therapeutics Limited
  • Atara Biotherapeutics, Inc.
  • Celluris
  • NeoTX
  • Kazia Therapeutics Limited

9. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact